Hi您好,欢迎来到科博会

第二十四届中国北京国际科技产业博览会

The 24th China Beijing International High-tech Expo

Hi您好,欢迎来到科博会

第二十四届中国北京国际科技产业博览会

The 24th China Beijing International High-tech Expo

锝[99Tc]亚甲基二膦酸盐注射液

 

项目名称 锝[99Tc]亚甲基二膦酸盐注射液

项目单位 成都云克药业有限责任公司

所属行业 生物医药

项目地点 四川成都

项目总投资 1800万:固定资产投资1500万,流动资金300万

项目建设期 

招商意向 

工艺技术简介 

项目简介 本产品是人工微量元素锝[99Tc]与亚甲基二膦酸盐的螯合物,用于治疗类风湿性关节炎等自身免疫性疾病及骨科疾病,毒副作用少且轻微,消炎镇痛有效率高,起效时间短、并具有生物制剂的破骨细胞抑制和骨关节修复作用。

项目市场前景 2009年销售额为5000万元,税后利润1500万元。预计2015年产品年销售额达到3亿元。

企业简介 公司专业从事放射性药品的产品开发、生产与销售,公司由原中国核动力研究设计院成都同位素应用技术研究所改制,为四川省建设创新型企业的培育企业,国家高新技术企业。资产总额6000万元,注册资金3072万元,员工114人。

其他说明 锝[99Tc]亚甲基二膦酸盐注射液公司首创的国家发明专利药物,获得2项目国家发明专利。

联系人 邓启民

电  话 028-81518504

传  真 028-85876577

E-mail dqmcq@yahoo.com.cn

网  址 www.yunke.cn

 

Name of Project Technetium [99Tc] Methylene Diphosphonate Injection

Sponsor Enterprise Chengdu Yunke Pharmaceutical Co. LTD

Industry Belonging Biological Medicine

Construction Site Chengdu, Sichuan

Total Investment RMB 18 million: investment with fixed assets of RMB 15 million, circulating funds of RMB 3 million

Construction Period 

Intentions 

Techniques 

Introduction to Project The product is combined by artificial trace element technetium [99Tc] and Methylene diphosphonate chelate, for the treatment of rheumatoid arthritis and other autoimmune diseases and bone diseases, with few and mild side effects, anti-inflammatory analgesic effective rate, onset time is short, and with biological agents inhibiting osteoclast function and bone and joint repair.

Market The sale of product is RMB 50 million in 2009, the profit after tax is 15 RMB millions. Product sales in 2015 expected to reach RMB 300 million.

Introduction to Enterprise Radioactive pharmaceuticals company engaged in product development, production and sales, the company former Nuclear Power Institute of China, Chengdu Institute of Isotope Applications restructuring, for the construction of innovative enterprises in Sichuan Province the cultivation of enterprise, the state high-tech enterprises. Total assets of RMB 60 million, registered capital of RMB 30.72 million, 114 employees.
Remark Technetium [99Tc] Methylene diphosphonate Injection got the National Invention Patent in Medicine realm originally, and got 2 item national invention-patent.

Contact Person Qimin, Deng

Tel 028-81518504

Fax 028-85876577

E-mail dqmcq@yahoo.com.cn

Website www.yunke.cn

  • 展览会
  • 虚拟展馆
  • 展商在线
  • 返回顶部